Current Status of Baricitinib as a Repurposed Therapy for COVID-19

The emergence of the COVID-19 pandemic has mandated the instant (re)search for potential drug candidates. In response to the unprecedented situation, it was recognized early that repurposing of available drugs in the market could timely save lives, by skipping the lengthy phases of preclinical and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Saber-Ayad, Maha, Hammoudeh, Sarah, Abu-Gharbieh, Eman, Hamoudi, Rifat, Tarazi, Hamadeh, Al-Tel, Taleb H., Hamid, Qutayba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308612/
https://www.ncbi.nlm.nih.gov/pubmed/34358107
http://dx.doi.org/10.3390/ph14070680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308612/
https://www.ncbi.nlm.nih.gov/pubmed/34358107
http://dx.doi.org/10.3390/ph14070680

Ejemplares similares